Novel treatment of systemic lupus erythematosus: belimumab is now available for Russian patients over 5 years old

Novel treatment of systemic lupus erythematosus: belimumab is now available for Russian patients over 5 years old

.

Bibliographic Details
Main Author:	article editorial
Format:	Article
Language:	English
Published:	Paediatrician Publishers, LLC 2020-02-01
Series:	Pediatričeskaâ Farmakologiâ
Online Access:	https://www.pedpharma.ru/jour/article/view/1796

Similar Items

Belimumab in systemic lupus erythematosus
by: Ankita Srivastava
Published: (2016-01-01)

EXPERIENCE WITH BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: E. A. Aseeva, et al.
Published: (2015-09-01)

BELIMUMAB: ADVANCES IN DRUG THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS
by: Evgeny Lvovich Nasonov, et al.
Published: (2012-10-01)

Management of Pediatric Systemic Lupus Erythematosus: Focus on Belimumab
by: Guzman M, et al.
Published: (2020-06-01)

Successful treatment of systemic lupus erythematosus pleuropericarditis with belimumab
by: Irene Carrión-Barberà, et al.
Published: (2019-07-01)

Pharmacoeconomic analysis of using belimumab for the treatment of systemic lupus erythematosus
by: A. G. Tolkushin, et al.
Published: (2018-11-01)

Sequential therapy with rituximab and belimumab in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2020-11-01)

New possibilities of pharmacotherapy for systemic lupus erythematosus: A place of belimumab
by: E. L. Nasonov
Published: (2014-12-01)

Efficacy of a sequential treatment by belimumab in monogenic systemic lupus erythematosus
by: Lujayn Akbar, et al.
Published: (2020-10-01)

Cost-effectiveness analysis of Belimumab in patients with systemic lupus erythematosus in Spain
by: Silvia Díaz-Cerezo, et al.
Published: (2015-02-01)

Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus
by: Ioannis Parodis, et al.
Published: (2020-05-01)

Budget Impact Analysis Of Subcutaneous Belimumab In Patients With Systemic Lupus Erythematosus In Spain
by: Cevey M, et al.
Published: (2019-12-01)

An update on belimumab for the treatment of lupus
by: Aikaterini Thanou-Stavraki, et al.
Published: (2011-02-01)

Impact of belimumab on patient-reported outcomes in systemic lupus erythematosus: review of clinical studies
by: Bangert E, et al.
Published: (2019-01-01)

Experience of long-term belimumab use in patients with systemic lupus erythematosus (a case report)
by: Natalia Gennadyevna Klyukvina
Published: (2013-06-01)

BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus
by: Woori Shin, et al.
Published: (2018-03-01)

Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents
by: Leanna M. Wise, et al.
Published: (2020-06-01)

Belimumab in the treatment of Portuguese Systemic Lupus Erythematosus patients: a real-life multicenter study
by: Bruno Miguel Fernandes, et al.
Published: (2020-07-01)

Safety of belimumab in association with denosumab in a patient affected by Lupus Erythematosus: a case report
by: Marco Scarati, et al.
Published: (2017-04-01)

Health Technology Assessment of Belimumab: A New Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus
by: Maria Lucia Specchia, et al.
Published: (2014-01-01)

A Rare Case of Prototheca Algaemia in a Patient with Systemic Lupus Erythematosus and Recent Belimumab Infusion
by: Carolina Mejia-Otero, et al.
Published: (2012-01-01)

Subcutaneous formulation of belimumab in treatment of systemic lupus erythematosus: a critical review with focus on safety and satisfaction
by: Ahmed HMA, et al.
Published: (2018-11-01)

Successful treatment with belimumab of severe systemic lupus erythematosus not responding to standard therapy: a case report
by: Ottavia Magnani, et al.
Published: (2016-03-01)

ONE CASE OF TOXIC EPIDERMAL NECROLYSIS AFTER TREATMENT WITH BELIMUMAB IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: Madalina Duna, et al.
Published: (2019-09-01)

12 Belimumab helps lupus patients to achieve lupus targets
by: Andrea Doria
Published: (2020-09-01)

Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies
by: Luca Petricca, et al.
Published: (2020-10-01)

RESULTS OF AN OBSERVATIONAL PROSPECTIVE STUDY OF THE EFFICACY AND SAFETY OF BELIMUMAB (BENLYSTA®) IN SYSTEMIC LUPUS ERYTHEMATOSUS IN REAL CLINICAL PRACTICE
by: E. A. Aseeva, et al.
Published: (2016-03-01)

Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis.
by: Francesca Pierotti, et al.
Published: (2015-01-01)

Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis plan
by: Patrick Muller, et al.
Published: (2020-07-01)

Pharmacokinetics, Pharmacodynamics and Safety of Belimumab in Chinese Patients with Systemic Lupus Erythematosus: A Phase I, Open-Label Study
by: Jing Zhang, et al.
Published: (2020-01-01)

Patient Satisfaction And Disease Control In Patients With Systemic Lupus Erythematosus Is Not Affected By Switching From Intravenous Belimumab To Subcutaneous Injections
by: Mucke J, et al.
Published: (2019-11-01)

Within-trial economic analysis of flare data from the BLISS-SC trial of subcutaneous belimumab in systemic lupus erythematosus
by: Tasneem Lokhandwala, et al.
Published: (2021-09-01)

Clinical Efficacy of Routinely Administered Belimumab on Proteinuria and Neuropsychiatric Lupus
by: Marlene Plüß, et al.
Published: (2020-05-01)

Neuropsychiatric systemic lupus erythematosus: where are we now?
by: M. Padovan, et al.
Published: (2011-09-01)

Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab
by: Francesca Regola, et al.
Published: (2019-04-01)

Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea
by: Damon Bass, et al.
Published: (2021-08-01)

New treatment options for lupus &ndash; a focus on belimumab
by: Chiche L, et al.
Published: (2012-01-01)

Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus
by: Azita Sohrabian, et al.
Published: (2019-11-01)

Letter in reply: Crusted scabies mimicking a lupus flare after rituximab and belimumab
by: Grigoriy Androsov, BS, et al.
Published: (2021-10-01)

PECULIARITIES OF SYSTEMIC LUPUS ERYTHEMATOSUS IN RUSSIANS AND GEORGIANS
by: Z S Alekberova, et al.
Published: (2001-04-01)

Cannot write session to /tmp/vufind_sessions/sess_kc0j0ng6f2fh93d2kjns6u7tll